Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

MIRACLE Mechanically Interlocked Radiotracers Chelators for Efficient Cancer Therapy

Coordinator
University of Warwick, United Kingdom
Runs
1 September 2026 to 31 August 2028
Status
Running
EU funding
€260k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101282487

What the project is doing

In the project's own words, from its summary on CORDIS.

Cancer is a leading global cause of death, with cases projected to rise sharply over the next decades. Radionuclide therapy (RNT) offers a highly selective alternative to conventional radiation treatments, using radiometal chelates for targeted tumour eradication. Despite clinical successes, current radiotracers face limitations including off-target toxicity, suboptimal pharmacokinetics, and insufficient stability. Mechanically Interlocked RAdiotracers CheLators (MIRACLEs) address these challenges by developing mechanically interlocked molecules (MIMs), such as rotaxanes and catenanes, as next-generation radiotracers.

These structures enable modular synthesis, tunable dynamics, and stimulus-responsiveness, allowing “smart” tracers with enhanced protein targeting, biodistribution control and metabolic stability. By integrating DOTA/DO3A scaffolds within mechanically interlocked architectures, mechanical bonds decouple thermodynamic affinity from kinetic inertness, providing steric shielding and addressing a key failure mode of conventional radiochelates.

This project will generate mechanically interlocked radiotracers (MIRTs) with improved in vivo stability, precise tissue-specific dosimetry, and efficient clearance. By combining supramolecular chemistry with radiopharmaceutical design, MIRACLE aims to deliver radiotheranostic agents with superior selectivity, safety and translational potential for clinical oncology.

Topics

Who is involved

OrganisationCityCountryRole
University of WarwickCoventryUnited KingdomCoordinator
Universitat ZurichZurichSwitzerlandAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI